Venture Investors Health Fund

Venture Investors Health Fund, also known as Venture Investors and more recently rebranded Clarevia, is one of the Midwest's longest-established healthcare-dedicated venture capital firms, headquartered in Madison, Wisconsin with an office in Ann Arbor, Michigan. Tracing its roots to the early 1980s, when it began as Madison Capital Corporation with just $1M under management, the firm has built a roughly four-decade legacy and today manages around $350M in assets. It invests in early-stage healthcare and life-sciences companies developing patient-facing innovations across biopharmaceuticals and therapeutics, medical devices, diagnostics and tools, and digital health, with historical strength in oncology, infectious disease and ophthalmology and an expanding focus on behavioral and women's health, willing to lead. The firm prefers companies with a Midwest presence but national reach, leveraging its proximity to world-class research universities. In its most recent, seventh, fund it closed $80M, with first-check sizes ranging from $500,000 to $4M and similar or larger amounts reserved for follow-on rounds. New portfolio companies funded include Elephas Biosciences, Rivermark Medical, Sanacor, Ten Bay Bio and EarliTec Diagnostics. Over its history the firm has made well over 100 investments and recorded roughly 50 exits. Its leadership includes Executive Managing Director Jim Adox, longtime Managing Director John Neis, with the firm since 1985, and Principal Jenni Le. By concentrating exclusively on healthcare and life sciences and leveraging its university ties, Venture Investors Health Fund backs early-stage, patient-facing innovation across the Midwest and beyond.